Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 6-MTH group results

Oct 29 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2018        Sep 30, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              129.49              138.63           269.00    
                   (-6.6 pct)          (-1.7 pct)       (-4.0 pct)  
  Operating           16.99               15.18            33.00    
                   (+11.9 pct)         (-8.9 pct)       (-10.8 pct) 
  Recurring           22.71               17.85            39.50    
                   (+27.2 pct)         (-6.7 pct)       (-6.3 pct)  
  Net                 42.43               12.02            55.50    
                  (+253.1 pct)         (-11.0 pct)      (+75.2 pct) 
  EPS              531.62 yen          150.38 yen       694.62 yen  
  EPS Diluted      531.14 yen          150.26 yen                   
  Ann Div                              110.00 yen       110.00 yen  
  -Q2 div           50.00 yen           50.00 yen                   
  -Q4 div                               60.00 yen        60.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news